Nevertheless, a negative staining in a tumor biopsy taken at the time point of diagnosis or during primary surgery does not exclude induction and/or expansion of ESR2-positive tumor cells during fractionated radiotherapy. This evidence concerns the gene ESR2 and neoplasm.